$IDEX News- Ideanomics Signs $113M Procurement and
Post# of 102065
![Avatar](/images/ProfileImages/1860257230_1592913057123.jpg)
https://investors.ideanomics.com/2020-05-07-I...-Financing
Analyst Report - Target Price $1.82
“We model CY22 EPS of $0.12 and apply a conservative 15x PE multiple to arrive at an intrinsic value of $1.82/share.”
Strong fundamentals and cheap valuation make a compelling investment case. We expect IDEX’s topline to climb from $39 million in CY20 (back-half ended) to $89 million in CY22. Gross margin will remain stable around ~95% while EBITDA margin is likely to expand from ~23% in CY20 to ~32% in CY22 as the company benefits from economies of scale. More importantly, IDEX will generate positive FCF starting this year and its RoE will reach 28% by CY22. We model CY22 EPS of $0.12 and apply a conservative 15x PE multiple to arrive at an intrinsic value of $1.82/share.
Source: Intro-Act Analyst Report April 20,2020
Copyright: Copyright 2019 Intro-act, LLC (Intro-act).
https://www.intro-act.com/uploads/profile_doc...OjxDLfSEZ4
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)